[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @lasyavavilala15 Jahnavi Lasyapriya Vavilala Jahnavi Lasyapriya Vavilala posts on X about $8750t, $4568t, $6417t the most. They currently have X followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1974311278639493120/interactions)  - X Week XXX +147% ### Mentions: X [#](/creator/twitter::1974311278639493120/posts_active)  ### Followers: X [#](/creator/twitter::1974311278639493120/followers)  - X Week X +50% ### CreatorRank: undefined [#](/creator/twitter::1974311278639493120/influencer_rank)  ### Social Influence **Social topic influence** [$8750t](/topic/$8750t), [$4568t](/topic/$4568t), [$6417t](/topic/$6417t) ### Top Social Posts Top posts by engagements in the last XX hours "Daiichi Sankyo" [X Link](https://x.com/lasyavavilala15/status/1998136102100902230) 2025-12-08T21:02Z X followers, X engagements "Daiichi Sankyo" [X Link](https://x.com/lasyavavilala15/status/1998146883290616227) 2025-12-08T21:45Z X followers, X engagements "Daiichi Sankyo presents data from five breast cancer trials at SABCS: DESTINY-Breast11 DESTINY-Breast05 DESTINY-Breast09 DESTINY-Breast03 featuring ENHERTU and TROPION-Breast02 with DATROWAY showing overall survival improvement in triple negative breast cancer" [X Link](https://x.com/lasyavavilala15/status/1998146884196618502) 2025-12-08T21:45Z X followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@lasyavavilala15 Jahnavi Lasyapriya VavilalaJahnavi Lasyapriya Vavilala posts on X about $8750t, $4568t, $6417t the most. They currently have X followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social topic influence $8750t, $4568t, $6417t
Top posts by engagements in the last XX hours
"Daiichi Sankyo"
X Link 2025-12-08T21:02Z X followers, X engagements
"Daiichi Sankyo"
X Link 2025-12-08T21:45Z X followers, X engagements
"Daiichi Sankyo presents data from five breast cancer trials at SABCS: DESTINY-Breast11 DESTINY-Breast05 DESTINY-Breast09 DESTINY-Breast03 featuring ENHERTU and TROPION-Breast02 with DATROWAY showing overall survival improvement in triple negative breast cancer"
X Link 2025-12-08T21:45Z X followers, XX engagements
/creator/x::lasyavavilala15